Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Darunavir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 871Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lupin receives tentative FDA approval for generic Darunavir
    Lupin receives tentative FDA approval for generic Darunavir

    06 Feb 2025

    // EXPRESS PHARMA

    https://www.expresspharma.in/lupin-receives-tentative-fda-approval-for-generic-darunavir-combination-tablets/https://www.expresspharma.in/lupin-receives-tentative-fda-approval-for-generic-darunavir-combination-tablets/

    EXPRESS PHARMA
    06 Feb 2025
    Share Share
    Annora`s Generics Darunavir Receive Tentative Approval in US
    Annora`s Generics Darunavir Receive Tentative Approval in US

    21 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216168

    FDA
    21 Jan 2025
    Share Share
    J&J seeks expanded approvals for paediatric HIV-1 therapy
    J&J seeks expanded approvals for paediatric HIV-1 therapy

    05 Jun 2024

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/johnson-johnson-approvals-hiv-1/

    PHARMACEUTICAL TECHNOLOGY
    05 Jun 2024
    Share Share
    Mylan's Generic Darunavir Receives Tentative Approval in the U.S.
    Mylan's Generic Darunavir Receives Tentative Approval in the U.S.

    26 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202136

    FDA
    26 Mar 2024
    Share Share
    Zydus gets USFDA nod for antiviral drug used in HIV treatment
    Zydus gets USFDA nod for antiviral drug used in HIV treatment

    15 Dec 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-gets-usfda-nod-for-antiviral-drug-used-in-hiv-treatment/articleshow/106020624.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    15 Dec 2023
    Share Share
    Aurobindo Pharma gets USFDA nod for HIV drug
    Aurobindo Pharma gets USFDA nod for HIV drug

    29 Nov 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-usfda-nod-for-hiv-drug/articleshow/105586693.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    29 Nov 2023
    Share Share